Skip to main content

Table 1 Baseline characteristics of included patients

From: Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications

 

IVR and trabeculectomy with MMC (n = 18)

Ahmed valve surgery (n = 19)

P value

Age (y)

62.3 ± 10.8

56.7 ± 13.6

0.54

Sex

   

 Male

 Female

11(61.1 %)

7(38.9 %)

10(52.6 %)

9(47.4 %)

0.74

Systemic diseases

   

Hypertention

Diabetes mellitus

11(61.1 %)

6(33.3 %)

12(63.2 %)

9(47.4 %)

 

Causes of NVG

   

PDR

CRVO

6(33.3 %)

10(55.6 %)

8(42.1 %)

8(42.1 %)

 

BRVO

 

1(5.3 %)

 

After intraocular surgery

2(11.1 %)

1(5.3 %)

 

Ischemic optic neuropathy

 

1(5.3 %)

 

Lens status

   

Phakic

Intraocular lens

16(88.8 %)

2(11.1 %)

13(68.4 %)

6(31.6 %)

 

Baseline IOP (mmHg)

57.1 ± 8.88

49.8 ± 11.8

0.12

BCVA (logMAR)

   

NLP

LP

others

3

2

2.42 ± 0.68

3

3

2.51 ± 0.84

0.68

Pain grade (NRS)

6.44 ± 0.78

5.68 ± 1.00

0.33

  1. Abbreviations: NVG neovascular glaucoma, PDR proliferative diabetic retinopathy, CRVO central retinal vein occlusion, BRVO branch retinal vein occlusion, IOP intraocular pressure, BCVA best corrected visual acuity, NLP no light perception, LP light perception, IVR intravitreal ranibizumab, MMC mitomycin C